You are here
P&T® Journal contents for March 2008
Presentations cover a short course of treatment with capecitabine (Xeloda), docetaxel (Taxotere), and trastuzumab (Herceptin); a study of the aromatase inhibitors letrozole (Femara) and zoledronic acid (Zometa) and their effect on bone loss; the aromatase inhibitors and tamoxifen (Nolvadex); and a trial of capecitabine plus ixabepilone (Ixempra) compared with ixabepilone monotherapy.
Topics include two new agents: ciclesonide (Alvesco Inhalation Aerosol) for the maintenance treatment of asthma and etravirine (Intelence) for adults with HIV infection. A new indication for colesevelam (Welchol) to improve glycemic control in type-2 diabetes is also discussed.
The authors conducted a study to determine whether patients who were not using insulin were following guidelines for self-monitoring of blood glucose. After a new software package was implemented at their institution, the reduced number of excess test strips led to cost savings and improved compliance.
Continuing Education Credit
The authors describe the pathophysiology and pharmacotherapy of a common complication of diabetes that causes significant morbidity and mortality.